My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Merck & Co (NY:MRK)

92.93 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9

...

96 97 Next >

3 Reasons Investors Love Merck (MRK)

November 05, 2025

Although Merck (currently trading at $84.57 per share) has gained 7% over the last six months, it has trailed the S&P 500’s 21.3% return during that period. This may have investors wondering how to...

Via StockStory

Topics Stocks Supply Chain

MarketMinute: The Rise of Precision Swine Farming – A New Frontier in Agri-Tech Investment

November 05, 2025

The global agricultural landscape is undergoing a profound transformation, with specialized niche markets emerging as significant drivers of innovation and investment. Among these, the precision swine...

Via MarketMinute

Topics Artificial Intelligence Supply Chain

Obesity Drugmakers Face Shifting Tides: Novo Nordisk Plunges While Eli Lilly Soars

November 05, 2025

The burgeoning market for obesity and diabetes treatments, particularly GLP-1 receptor agonists, is witnessing a dramatic divergence in fortunes among its leading players. As of November 5, 2025, Novo...

Via MarketMinute

Topics Economy

Merck Stock Rises Upon Receipt Of $700M In Funding For Experimental Cancer Drug ↗

November 04, 2025

Via Stocktwits

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns

November 05, 2025

Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design...

Via TokenRing AI

Topics Artificial Intelligence Intellectual Property

AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential

November 04, 2025

The burgeoning fields of cell and gene therapy (CGT) are on the cusp of a profound revolution, driven by the relentless advancements in artificial intelligence. This transformative impact was a central...

Via TokenRing AI

Topics Artificial Intelligence

Why Merck Is Sinking This Week ↗

November 04, 2025

Investors were unimpressed with Merck's Q3 financial results.

Via The Motley Fool

Topics Intellectual Property

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗

November 04, 2025

With yields of up to 7%, this trio of high-yield stocks are all industry-leading companies.

Via The Motley Fool

Topics Energy Stocks

AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio

November 01, 2025

The biopharmaceutical industry is undergoing an immediate and profound transformation, as Artificial Intelligence (AI) rapidly compresses timelines, drastically reduces costs, and significantly...

Via TokenRing AI

Topics Animal Testing Artificial Intelligence Economy

Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout

October 31, 2025

Thousand Oaks, CA – October 31, 2025 – Amgen (NASDAQ: AMGN), a leading biotechnology giant, has declared a quarterly dividend of $2.38 per share for the fourth quarter of 2025. This significant...

Via MarketMinute

Topics Intellectual Property

AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs

October 31, 2025

San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of...

Via TokenRing AI

Topics Artificial Intelligence Supply Chain

AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future

October 31, 2025

The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late...

Via TokenRing AI

Topics Animal Testing Artificial Intelligence Economy

Merck Q3 2025 Earnings Call Transcript ↗

October 31, 2025

Merck Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain ↗

October 30, 2025

As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.

Via Benzinga

Topics ETFs

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗

October 30, 2025

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome...

Via Benzinga

Topics Economy

Merck Ready For Larger Than $15 Billion Deals, Raises Annual Profit Outlook ↗

October 30, 2025

Merck shares dipped after strong earnings and higher profit guidance, as the company narrowed its 2025 sales forecast amid mixed product performance.

Via Benzinga

Merck’s (NYSE:MRK) Q3 Sales Top Estimates

October 30, 2025

Global pharmaceutical company Merck (NYSE:MRK) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 3.7% year on year to $17.28 billion. The company expects the full year’s revenue to be...

Via StockStory

Merck & Co. Inc. (NYSE:MRK) Q3 2025 Earnings Beat Expectations Despite Stock Decline ↗

October 30, 2025

Merck Q3 2025 earnings beat estimates with strong sales and EPS growth, driven by KEYTRUDA and WINREVAIR, yet shares fell on guidance.

Via Chartmill

Topics Earnings

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗

October 30, 2025

Via Benzinga

Dow Jones Stock Merck Tops Expectations, But Gardasil Challenges Remain ↗

October 30, 2025

The company sells a notable vaccine to prevent human papillomavirus. But sales are struggling.

Via Investor's Business Daily

Topics Earnings Stocks

Merck (MRK) Reports Earnings Tomorrow: What To Expect

October 28, 2025

Global pharmaceutical company Merck (NYSE:MRK) will be reporting earnings this Thursday morning. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

Looking At Merck & Co's Recent Unusual Options Activity ↗

October 28, 2025

Via Benzinga

Merck's New Cancer Therapy Combo Shows Significant Edge Over Rivals In Renal Cancer ↗

October 28, 2025

Merck and Eisai report Phase 3 results showing Welireg plus Lenvima significantly improved progression-free survival in advanced kidney cancer.

Via Benzinga

Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers

October 27, 2025

As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

3 Dividend-Paying Drug Stocks to Buy at a Discount ↗

October 27, 2025

Some of the largest drugmakers in the world are trading at attractive valuations. Are they worth buying?

Via The Motley Fool

Topics Intellectual Property

How Is The Market Feeling About Merck & Co Inc? ↗

October 27, 2025

Via Benzinga

3 Healthcare Stocks to Buy Hand Over Fist in October ↗

October 27, 2025

One growth stock, one high-yield stock, and one Dividend King -- you should find something you like here as October draws to a close.

Via The Motley Fool

Topics Intellectual Property

3 Healthcare Stocks That Are Screaming Deals Right Now ↗

October 26, 2025

These bargains could prove good for your financial health.

Via The Motley Fool

Topics Intellectual Property

Flash PMI: The Early Warning System Guiding the Federal Reserve's Hand

October 23, 2025

Flash Purchasing Managers' Index (PMI) data, a critical economic bellwether, continues to command significant attention from financial markets and policymakers alike. Released typically a week or two...

Via MarketMinute

Topics Bonds Economy Supply Chain

< Previous 1 2 3 4 5 6 7 8 9

...

96 97 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.